BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 16036612)

  • 1. From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance.
    Karin M; Gallagher E
    IUBMB Life; 2005; 57(4-5):283-95. PubMed ID: 16036612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
    Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
    Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun controls the efficiency of MAP kinase signaling by transcriptional repression of MAP kinase phosphatases.
    Sprowles A; Robinson D; Wu YM; Kung HJ; Wisdom R
    Exp Cell Res; 2005 Aug; 308(2):459-68. PubMed ID: 15950217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
    Eriksson M; Taskinen M; Leppä S
    J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
    Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
    Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological roles of SAPK/JNK signaling pathway.
    Nishina H; Wada T; Katada T
    J Biochem; 2004 Aug; 136(2):123-6. PubMed ID: 15496581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen induces VEGF expression through ERK, JNK and c-Jun/AP-1 activation in human umbilical vein endothelial cells.
    Lee CC; Chen SC; Tsai SC; Wang BW; Liu YC; Lee HM; Shyu KG
    J Biomed Sci; 2006 Jan; 13(1):143-56. PubMed ID: 16328781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids.
    Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M
    Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.
    Leppä S; Bohmann D
    Oncogene; 1999 Nov; 18(45):6158-62. PubMed ID: 10557107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
    Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
    Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
    Yu X; Luo A; Zhou C; Ding F; Wu M; Zhan Q; Liu Z
    Biochem Biophys Res Commun; 2006 Mar; 342(1):286-92. PubMed ID: 16480952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of gene expression by the amyloid precursor protein: inhibition of the JNK/c-Jun pathway.
    Kögel D; Schomburg R; Copanaki E; Prehn JH
    Cell Death Differ; 2005 Jan; 12(1):1-9. PubMed ID: 15592359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of JNK activation in apoptosis: a double-edged sword.
    Liu J; Lin A
    Cell Res; 2005 Jan; 15(1):36-42. PubMed ID: 15686625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.
    Johnson GL; Lapadat R
    Science; 2002 Dec; 298(5600):1911-2. PubMed ID: 12471242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: a new therapeutic target in Parkinson's disease.
    Silva RM; Kuan CY; Rakic P; Burke RE
    Mov Disord; 2005 Jun; 20(6):653-64. PubMed ID: 15719422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells.
    Reno EM; Haughian JM; Jackson TA; Thorne AM; Bradford AP
    Apoptosis; 2009 Jun; 14(6):809-20. PubMed ID: 19424800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration.
    Herdegen T; Waetzig V
    Oncogene; 2001 Apr; 20(19):2424-37. PubMed ID: 11402338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-S-Transferase as a selective inhibitor of oncogenic ras-p21-induced mitogenic signaling through blockade of activation of jun by jun-N-terminal kinase.
    Villafania A; Anwar K; Amar S; Chie L; Way D; Chung DL; Adler V; Ronai Z; Brandt-Rauf PW; Yamaizumii Z; Kung HF; Pincus MR
    Ann Clin Lab Sci; 2000 Jan; 30(1):57-64. PubMed ID: 10678584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.
    Nateri AS; Spencer-Dene B; Behrens A
    Nature; 2005 Sep; 437(7056):281-5. PubMed ID: 16007074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.